The Impact of a Patient Decision Aid on Treatment Choices for Patients With an Unexpected Malignant Colorectal Polyp
Launched by VEJLE HOSPITAL · Mar 17, 2023
Trial Information
Current as of July 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a special tool called a Patient Decision Aid (PtDA) can help patients make better treatment choices after finding a malignant colorectal polyp—essentially a growth in the colon that can be cancerous. Since there are different ways to manage this condition, like surgery or simply monitoring it, this study aims to see if using the PtDA during discussions with doctors can lead to improved decision-making compared to past experiences. The trial will also gather feedback from patients about their experiences and outcomes through questionnaires.
To participate in this study, you need to be between the ages of 65 and 74 and have had a malignant colorectal polyp removed through an endoscopy, with no signs of further disease spread. However, you won’t be able to join if you can’t give informed consent, have serious health issues that make surgery impossible, or have remaining cancer after your initial treatment. The trial is set to begin in early 2024 and is designed to help ensure that patients feel empowered and informed when making choices about their health care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Histopathologically verified malignant colorectal polyp removed endoscopically and CT-scan (and MRI if the malignant polyp was situated in the rectum) shows N0, M0 disease.
- Exclusion Criteria:
- • Inability to provide informed consent
- • Inoperable due to comorbidity
- • Known residual tumor left in situ after local resection, \>N0 or \>M0
About Vejle Hospital
Vejle Hospital is a leading healthcare institution in Denmark, dedicated to advancing medical research and enhancing patient care through innovative clinical trials. With a focus on multidisciplinary collaboration, Vejle Hospital leverages its state-of-the-art facilities and experienced research teams to conduct rigorous studies across various therapeutic areas. Committed to ethical standards and patient safety, the hospital aims to contribute valuable insights to the medical community, ultimately improving treatment outcomes and healthcare practices. Through its clinical trial initiatives, Vejle Hospital strives to foster a culture of scientific excellence and drive advancements in health and medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Helene Würtz, MD
Principal Investigator
Vejle Hospital, Center for Shared Decision Making and Surgical Department
Karina D Steffensen, Prof PhD MD
Study Chair
Center For Shared Decision Making, Vejle Hospital
Hans B Rahr, Prof Dr MD
Study Chair
Surgical Department, Vejle Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials